In support of this finding, many studies have conclusively stated with evidence that the interaction between anti-Hsp70 and anti-Hsp60 correlates with progression, poor prognosis, and severity observed in asthmatic patients, as previously suggested by Shingai and colleagues in a patient with autoimmune liver disease [102] and Mycobacterium Hsp65 in chronic human atherosclerosis [103]. The gene discussed is HSPD1; the disease is autoimmune hepatitis.